A double-blind dose-finding pilot study of docosahexaenoic acid (DHA) for major depressive disorder.
about
Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysisA double-blind, randomized controlled trial of ethyl-eicosapentaenoate for major depressive disorderSupplementation with Omega-3 Fatty Acids in Psychiatric Disorders: A Review of Literature DataEmerging targets for antidepressant therapiesDietary intake of fish, omega-3, omega-6 polyunsaturated fatty acids and vitamin D and the prevalence of psychotic-like symptoms in a cohort of 33,000 women from the general populationEffects of omega 3 fatty acids supplementation in behavior and non-neurodegenerative neuropsychiatric disorders.N-3 (omega-3) Fatty acids in postpartum depression: implications for prevention and treatment.Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof-of-concept study.Lipid correlates of antidepressant response to omega-3 polyunsaturated fatty acid supplementation: A pilot study.Considerations regarding neuropsychiatric nutritional requirements for intakes of omega-3 highly unsaturated fatty acidsOmega-3 Polyunsaturated Fatty Acids in Prevention of Mood and Anxiety Disorders.Omega-3 fatty acid augmentation of citalopram treatment for patients with major depressive disorder.Nutrition, psychoneuroimmunology and depression: the therapeutic implications of omega-3 fatty acids in interferon-α-induced depression.(N-3) Fatty acids: molecular role and clinical uses in psychiatric disorders.Long Chain Omega-3 Polyunsaturated Fatty Acid Supplementation Alleviates Doxorubicin-Induced Depressive-Like Behaviors and Neurotoxicity in Rats: Involvement of Oxidative Stress and Neuroinflammation.The impact of omega-3 fatty acids on depressive disorders and suicidality: can we reconcile 2 studies with seemingly contradictory results?Current Trends in Identifying Rapidly Acting Treatments for DepressionIntracellular- and extracellular-derived Ca(2+) influence phospholipase A(2)-mediated fatty acid release from brain phospholipids.What is the effectiveness of the use of polyunsaturated fatty acid omega-3 in the treatment of depression?The use of omega-3 fatty acids in mental illness.Omega-3 polyunsaturated fatty acids for major depressive disorder.ω-3 and major depression: a review.Nutrition, mood and behaviour: a review.Evidence for Inflammation-Associated Depression.The status of nutraceuticals for the treatment of depression.Update and critique of natural remedies as antidepressant treatments.Dietary intake of fish and PUFA, and clinical depressive and anxiety disorders in women.Fish oil and depression: The skinny on fats.Adjunctive low-dose docosahexaenoic acid (DHA) for major depression: An open-label pilot trial.Youth depression alleviation: the Fish Oil Youth Depression Study (YoDA-F): A randomized, double-blind, placebo-controlled treatment trial.Effects of omega-3 on behavioral and biochemical parameters in rats submitted to chronic mild stress.The effect of low-dose omega 3 fatty acids on the treatment of mild to moderate depression in the elderly: a double-blind, randomized, placebo-controlled study.The VITamin D and OmegA-3 TriaL-Depression Endpoint Prevention (VITAL-DEP): Rationale and design of a large-scale ancillary study evaluating vitamin D and marine omega-3 fatty acid supplements for prevention of late-life depression.
P2860
Q24634019-3A7FA47F-5FF5-48F5-A456-1ABDB861EDE7Q24634050-BA00CC93-4B98-4996-968E-861C14A56F71Q26740508-3F735BD5-38FC-48AD-8367-72EECEB07BCCQ28247614-0BD50A6F-44B3-4E56-920E-49E08E8A2682Q33588118-B32AA3DC-7AF8-41A6-95B7-C9671AE9BB4BQ34275382-21BB0491-7C25-46B2-98D5-66CD60EBEA27Q34340306-6A219711-CD83-412F-B686-7D8C1333EF3CQ34468355-5DE06C7D-72F4-4749-83A8-9CF58C5243D0Q34555244-ABE3ACE2-5E73-4845-801B-FB0894299A93Q35239204-CFD1FB2F-E694-45B9-A8CA-A533DF34F27AQ35965592-2098205E-1EFC-4A7A-B22F-93424BC43DF1Q36034152-0515089C-A6B0-4013-8DE0-55EBC49A59BDQ36327782-6ACB1FED-F9C6-4AE9-8669-4D042511F2CDQ36830364-D07ACED6-38A5-4A4C-B0C7-D484C50B43FCQ36846411-802F5A96-AF0F-4B66-99DA-8697CCD067CCQ37075354-8913B8BE-4712-4326-A552-A0ED957F578BQ37210886-7CA59C7D-FAD3-423B-8C5F-4C019F3382A7Q37328073-D8C69EA2-B30F-492C-93D5-A5C8E9AD0A44Q37768443-9AF2DA57-E150-4D2F-93F8-5495F149722FQ37937303-8D9931AA-C773-4CBA-A4C7-E38A37A35DC2Q38148244-3A6F7289-5D2D-451D-B7D1-46A6D86149E7Q38241706-F887A394-E920-4FBF-9B19-F8396C82D6A4Q38764853-415D30AE-7C69-4C71-97BE-52042F55F016Q38843528-E52553DF-ECB1-4527-8D81-29A8D12D5524Q42089489-96D69241-15DD-448D-B96A-823993E1DF80Q42690784-A0B76D92-429E-4BFD-A674-D20C2125438FQ45169948-D407E563-9CE9-4927-AAB9-128F39805797Q47280324-FD23DCDC-F204-4FBD-8118-E54B44CD13D4Q47761010-0A02F961-D511-48F4-9E7E-5611408306E3Q48231913-4B7CB8F1-C77C-4DF4-9231-0EFFE6FA4BE4Q48266634-124DD41C-16BE-40A4-AFB4-31EDABBE1584Q48911413-9B75ADCC-5752-49FC-8E16-00CF37EE7E8AQ52662001-AF82DA27-A8E9-4578-901C-EE6AB0ABA711
P2860
A double-blind dose-finding pilot study of docosahexaenoic acid (DHA) for major depressive disorder.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
A double-blind dose-finding pi ...... for major depressive disorder.
@en
A double-blind dose-finding pilot study of docosahexaenoic acid
@nl
type
label
A double-blind dose-finding pi ...... for major depressive disorder.
@en
A double-blind dose-finding pilot study of docosahexaenoic acid
@nl
prefLabel
A double-blind dose-finding pi ...... for major depressive disorder.
@en
A double-blind dose-finding pilot study of docosahexaenoic acid
@nl
P2093
P1476
A double-blind dose-finding pi ...... for major depressive disorder
@en
P2093
Andrew A Nierenberg
Catherine Best-Popescu
Christina M Dording
David Mischoulon
George I Papakostas
Jessica L Murakami
Maurizio Fava
Michael Laposata
Shamsah B Sonawalla
Shirley L Wu
P304
P356
10.1016/J.EURONEURO.2008.04.011
P407
P577
2008-06-06T00:00:00Z